{"entity":{"type":"insider","cik":"0001746240","url":"/insider/0001746240","json_url":"/insider/0001746240.json","name":"KIM AUSTIN D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":15,"first":"2019-12-13","last":"2024-01-09","span_basis":"filed_date"},"name_variants":[{"name":"KIM AUSTIN D.","source":"filing","n_filings":15,"first_seen":"2019-12-13","last_seen":"2024-01-09"}],"transactions":[{"id":2697848,"accession":"0001209191-24-001267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001267","line_url":"/filing/0001209191-24-001267#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":590.0,"shares_display":"590","price_per_share":29.96,"price_display":"29.96","price_state":"stated","total_value":17676.4,"total_display":"17,676.40","total_whole":"17,676","shares_owned_after":46901.0,"shares_owned_after_display":"46,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8547375,"accession":"0001209191-23-052390","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-052390","line_url":"/filing/0001209191-23-052390#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16369.0,"shares_display":"16,369","price_per_share":21.96,"price_display":"21.96","price_state":"stated","total_value":359463.24,"total_display":"359,463.24","total_whole":"359,463","shares_owned_after":45857.0,"shares_owned_after_display":"45,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-06","filed_date":"2023-10-06","scope":"insider"},{"id":8745067,"accession":"0001209191-23-026746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-026746","line_url":"/filing/0001209191-23-026746#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":917.0,"shares_display":"917","price_per_share":21.18,"price_display":"21.18","price_state":"stated","total_value":19422.06,"total_display":"19,422.06","total_whole":"19,422","shares_owned_after":25513.0,"shares_owned_after_display":"25,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8365624,"accession":"0001209191-23-023861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023861","line_url":"/filing/0001209191-23-023861#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1456.0,"shares_display":"1,456","price_per_share":18.16,"price_display":"18.16","price_state":"stated","total_value":26440.96,"total_display":"26,440.96","total_whole":"26,441","shares_owned_after":23425.0,"shares_owned_after_display":"23,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider"},{"id":8182833,"accession":"0001209191-23-013469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013469","line_url":"/filing/0001209191-23-013469#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":803.0,"shares_display":"803","price_per_share":18.78,"price_display":"18.78","price_state":"stated","total_value":15080.34,"total_display":"15,080.34","total_whole":"15,080","shares_owned_after":20108.0,"shares_owned_after_display":"20,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8542617,"accession":"0001209191-23-002894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002894","line_url":"/filing/0001209191-23-002894#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":589.0,"shares_display":"589","price_per_share":17.1303,"price_display":"17.13","price_state":"stated","total_value":10089.7467,"total_display":"10,089.75","total_whole":"10,090","shares_owned_after":18697.0,"shares_owned_after_display":"18,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6455355,"accession":"0001209191-22-026938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-026938","line_url":"/filing/0001209191-22-026938#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP,General Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP,General Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,General Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":894.0,"shares_display":"894","price_per_share":18.182,"price_display":"18.18","price_state":"stated","total_value":16254.708,"total_display":"16,254.71","total_whole":"16,255","shares_owned_after":16742.0,"shares_owned_after_display":"16,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6845212,"accession":"0001209191-22-013277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013277","line_url":"/filing/0001209191-22-013277#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":782.0,"shares_display":"782","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":18611.6,"total_display":"18,611.60","total_whole":"18,612","shares_owned_after":14631.0,"shares_owned_after_display":"14,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-25","scope":"insider"},{"id":6843800,"accession":"0001209191-22-002750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002750","line_url":"/filing/0001209191-22-002750#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":574.0,"shares_display":"574","price_per_share":23.05,"price_display":"23.05","price_state":"stated","total_value":13230.7,"total_display":"13,230.70","total_whole":"13,231","shares_owned_after":13200.0,"shares_owned_after_display":"13,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-06","filed_date":"2022-01-10","scope":"insider"},{"id":5490677,"accession":"0001209191-21-029358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-029358","line_url":"/filing/0001209191-21-029358#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1054.0,"shares_display":"1,054","price_per_share":20.33,"price_display":"20.33","price_state":"stated","total_value":21427.82,"total_display":"21,427.82","total_whole":"21,428","shares_owned_after":11371.0,"shares_owned_after_display":"11,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-04-30","scope":"insider"},{"id":5519591,"accession":"0001209191-21-008658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-008658","line_url":"/filing/0001209191-21-008658#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2107.0,"shares_display":"2,107","price_per_share":50.61,"price_display":"50.61","price_state":"stated","total_value":106635.27,"total_display":"106,635.27","total_whole":"106,635","shares_owned_after":9911.0,"shares_owned_after_display":"9,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-08","scope":"insider"},{"id":4137148,"accession":"0001209191-21-002834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002834","line_url":"/filing/0001209191-21-002834#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":53.34,"price_display":"53.34","price_state":"stated","total_value":36164.52,"total_display":"36,164.52","total_whole":"36,165","shares_owned_after":5518.0,"shares_owned_after_display":"5,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider"},{"id":2145868,"accession":"0001209191-20-056219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-056219","line_url":"/filing/0001209191-20-056219#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":45.1013,"price_display":"45.10","price_state":"stated","total_value":394636.375,"total_display":"394,636.38","total_whole":"394,636","shares_owned_after":3851.0,"shares_owned_after_display":"3,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-29","scope":"insider"},{"id":3197143,"accession":"0001209191-20-026619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-026619","line_url":"/filing/0001209191-20-026619#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1072.0,"shares_display":"1,072","price_per_share":49.22,"price_display":"49.22","price_state":"stated","total_value":52763.84,"total_display":"52,763.84","total_whole":"52,764","shares_owned_after":2441.0,"shares_owned_after_display":"2,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-01","scope":"insider"},{"id":8210691,"accession":"0001209191-19-060475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060475","line_url":"/filing/0001209191-19-060475#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001746240","owner_name":"KIM AUSTIN D.","owner_display_name":"KIM AUSTIN D.","owner_url":"/insider/0001746240","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":45.0615,"price_display":"45.06","price_state":"stated","total_value":788576.25,"total_display":"788,576.25","total_whole":"788,576","shares_owned_after":509.0,"shares_owned_after_display":"509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP,General Counsel, Secretary)","n_filings":15,"first_seen":"2019-12-13","last_seen":"2024-01-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746240","retrieved_at":"2026-08-24T18:47:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}